SAN DIEGO--(BUSINESS WIRE)--Nov. 18, 2005--Ligand Pharmaceuticals Incorporated (Pink Sheets:LGND) today announced preliminary revenue estimates for its third quarter of fiscal year 2005 and preliminary financial results for its first and second quarters of fiscal year 2005. The company also announced that the Form 10-K for fiscal year 2004 containing audited results for fiscal 2004, restated audited results for fiscal years 2003 and 2002, and a restatement of selected financial data for fiscal years 2001 and 2000 has been filed today with the Securities and Exchange Commission (SEC).
